TP53 and breast carcinoma: Overexpression of the BIRC5 gene in breast cancer cells upregulates the levels of MDM2 and downregulates the expression of the p53 gene thereby inhibiting the apoptotic effect induced by the p53 pathway (Wang et al., 2004).